Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10195334rdf:typepubmed:Citationlld:pubmed
pubmed-article:10195334lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10195334lifeskim:mentionsumls-concept:C0497327lld:lifeskim
pubmed-article:10195334lifeskim:mentionsumls-concept:C0038590lld:lifeskim
pubmed-article:10195334lifeskim:mentionsumls-concept:C0085200lld:lifeskim
pubmed-article:10195334lifeskim:mentionsumls-concept:C0242422lld:lifeskim
pubmed-article:10195334lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:10195334pubmed:issue1lld:pubmed
pubmed-article:10195334pubmed:dateCreated1999-5-25lld:pubmed
pubmed-article:10195334pubmed:abstractTextIn a retrospective clinicopathological study, we examined the substantia nigra (SN) of 48 dementia patients with SN Lewy bodies (LBs) to determine if the severity of degeneration correlated with either the occurrence of signs of parkinsonism at dementia presentation or with the frequency of treatment for parkinsonism during the disease course. The SN specimens were graded for microscopic degeneration using a semi-quantitative five-tiered scale. Whereas no correlation was found between the grade of degeneration and occurrence of signs at presentation (r = -0.16, p = 0.18), with 16 of 38 patients having had signs reported, a more severe grade was statistically correlated with an increased frequency of treatment during the course (r = 0.41, p = 0.004), with ten of 41 patients having been treated for parkinsonism. Contrary to our expectations, we found that fewer than half of the patients with the two most severe grades of degeneration presented with signs of parkinsonism or were ever treated for parkinsonism.lld:pubmed
pubmed-article:10195334pubmed:languageenglld:pubmed
pubmed-article:10195334pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195334pubmed:citationSubsetIMlld:pubmed
pubmed-article:10195334pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195334pubmed:statusMEDLINElld:pubmed
pubmed-article:10195334pubmed:issn0300-9564lld:pubmed
pubmed-article:10195334pubmed:authorpubmed-author:FreyW HWH2ndlld:pubmed
pubmed-article:10195334pubmed:authorpubmed-author:YangK HKHlld:pubmed
pubmed-article:10195334pubmed:authorpubmed-author:TOMSE CEClld:pubmed
pubmed-article:10195334pubmed:authorpubmed-author:AlaT ATAlld:pubmed
pubmed-article:10195334pubmed:issnTypePrintlld:pubmed
pubmed-article:10195334pubmed:volume106lld:pubmed
pubmed-article:10195334pubmed:ownerNLMlld:pubmed
pubmed-article:10195334pubmed:authorsCompleteYlld:pubmed
pubmed-article:10195334pubmed:pagination47-57lld:pubmed
pubmed-article:10195334pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10195334pubmed:meshHeadingpubmed-meshheading:10195334...lld:pubmed
pubmed-article:10195334pubmed:meshHeadingpubmed-meshheading:10195334...lld:pubmed
pubmed-article:10195334pubmed:meshHeadingpubmed-meshheading:10195334...lld:pubmed
pubmed-article:10195334pubmed:meshHeadingpubmed-meshheading:10195334...lld:pubmed
pubmed-article:10195334pubmed:meshHeadingpubmed-meshheading:10195334...lld:pubmed
pubmed-article:10195334pubmed:meshHeadingpubmed-meshheading:10195334...lld:pubmed
pubmed-article:10195334pubmed:meshHeadingpubmed-meshheading:10195334...lld:pubmed
pubmed-article:10195334pubmed:meshHeadingpubmed-meshheading:10195334...lld:pubmed
pubmed-article:10195334pubmed:meshHeadingpubmed-meshheading:10195334...lld:pubmed
pubmed-article:10195334pubmed:year1999lld:pubmed
pubmed-article:10195334pubmed:articleTitleClinical parkinsonism in dementia patients with substantia nigra Lewy bodies.lld:pubmed
pubmed-article:10195334pubmed:affiliationAlzheimer's Treatment and Research Center, Department of Neurology, Ramsey Clinic/HealthPartners, University of Minnesota, St. Paul, USA.lld:pubmed
pubmed-article:10195334pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10195334pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10195334lld:pubmed